Association between CD138-positive cell count in endometrial stroma and pregnancy outcomes after single blastocyst transfer
Journal of Reproductive Immunology · 2025-12 · 172 · 104796
DOI: 10.1016/j.jri.2025.104796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2025-12. Verfasst von Kazuki Nakao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo 160-0023, Japan. Hauptthemen laut MEDLINE: Endometrium, Syndecan-1, Single Embryo Transfer, Endometritis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
The impact of endometrial CD138-positive cell numbers on pregnancy outcomes in chronic endometritis (CE) remains uncertain. This study examined the association between CD138-positive cell counts in endometrial stroma and pregnancy results following frozen-thawed single blastocyst transfer (SBT) cycles. Approved by the institutional Ethics Committee, this retrospective case-control study included 166 infertile women under 40 years old who underwent frozen-thawed SBT with morphologically and developmentally good-quality blastocysts within 3 months of an endometrial biopsy for CD138 immunostaining between September 2020 and August 2021. Endometrial stromal CD138-positive cells were counted in 10 high-power fields (HPFs). Pregnancy outcomes were compared among groups with 0, 1-4, and ≥ 5 CD138-positive cells, comprising 71, 72, and 20 patients, respectively. Prior antibiotic treatment rates for CE were 53.5 %, 52.8 %, and 100 % in the 0, 1-4, and ≥ 5 cell groups, respectively (p < 0.001). The clinical pregnancy rates after SBT were 60.6 % (43/71), 66.7 % (48/72), and 35.0 % (7/20) for the respective groups, with lower rates in women with ≥ 5 positive cells compared to those with 0-4 (odds ratio: 0.31, 95 % confidence interval: 0.12-0.82, p = 0.02). Miscarriage rates did not differ significantly among the groups (25.6 %, 20.1 %, and 28.6 %; p = 0.81). The presence of five or more CD138-positive cells per 10 HPFs negatively affected pregnancy success after SBT, whereas patients with 1-4 positive cells may not require antibiotic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo 160-0023, Japan.
- Center for Reproductive Medicine and Endoscopy, Sugiyama Clinic Marunouchi, Tokyo 100-0005, Japan; Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo 113-8421, Japan. Electronic add…
- Center for Reproductive Medicine and Endoscopy, Sugiyama Clinic Marunouchi, Tokyo 100-0005, Japan.
Zitieren
APA
Nakao, K., Kuroda, K., Shiobara, K., Ishiyama, S., Moriyama, A., Kataoka, H., Horikawa, T., Takamizawa, S., Nakagawa, K., & Sugiyama, R. (2025). Association between CD138-positive cell count in endometrial stroma and pregnancy outcomes after single blastocyst transfer. Journal of Reproductive Immunology, 172, 104796. https://doi.org/10.1016/j.jri.2025.104796
Vancouver
Nakao K, Kuroda K, Shiobara K, Ishiyama S, Moriyama A, Kataoka H, et al. Association between CD138-positive cell count in endometrial stroma and pregnancy outcomes after single blastocyst transfer. Journal of Reproductive Immunology. 2025;172:104796. doi:10.1016/j.jri.2025.104796
BibTeX
@article{Nakao2025,
author = {Nakao, Kazuki and Kuroda, Keiji and Shiobara, Keisuke and Ishiyama, Shunsuke and Moriyama, Azusa and Kataoka, Hisayo and Horikawa, Takashi and Takamizawa, Satoru and Nakagawa, Koji and Sugiyama, Rikikazu},
title = {Association between CD138-positive cell count in endometrial stroma and pregnancy outcomes after single blastocyst transfer},
journal = {Journal of Reproductive Immunology},
year = {2025},
volume = {172},
pages = {104796},
doi = {10.1016/j.jri.2025.104796}
}
EUVIMED